By Giulia Petroni
Sartorius AG said on Thursday that it would acquire a majority stake in Germany-based laboratory technology company ALS Automated Lab Solutions GmbH for an undisclosed sum.
The pharmaceutical and laboratory-equipment supplier said it would initially buy 62.5% of ALS's shares on Jan. 3, while the rest will be bought in 2026.
ALS makes solutions for the automated analysis, selection and isolation of cells, according to the company. It currently employs around 30 people and is expected to generate sales in the high single-digit million-euro area this year, with a double-digit earnings before interest, taxes, depreciation and amortization margin.
Write to Giulia Petroni at firstname.lastname@example.org
(END) Dow Jones Newswires